as of the date of this press release and the Company
undertakes no duty to update any forward-looking statement to conform the
statement to actual results or changes in the company's expectations.
For more information, please contact:
China Pharma Holdings, Inc.
HC International, Inc.
-- FINANCIAL TABLES FOLLOW --
CHINA PHARMA HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
March 31, December 31,
Cash and cash equivalents $682,017 $1,830,335
Trade accounts receivable, less
allowance for doubtful accounts
of $3,019,930 and $2,440,852,
respectively 24,804,992 18,572,976
Other receivables, less allowance
for doubtful accounts of $64,230
and $43,908, respectively 476,749 413,596
Advances to suppliers 1,568,111 2,757,320
Inventory 14,810,192 14,448,771
Total Current Assets 42,342,061 38,022,998
Property and equipment, net of
accumulated depreciation of
$1,150,987 and $1,003,802,
Page: 1 2 3 4 5 6 7 8 9 Related biology technology :1
|SOURCE China Pharma Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved
. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex2
. DuPont Partnering with China to Increase Farm Productivity3
. China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network4
. China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc.5
. Syngenta To Build Major Global Biotech Research Center in Beijing, China6
. American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance7
. China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier8
. CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China9
. China Bio Energy Reports Fiscal 2007 Financial Results10
. Transgenomic Opens Pharmacogenomics Laboratory in China11
. China Pharma Holdings, Inc. Announces Record 2007 Year End Results